FPP and Inventia Sign Licensing and Supply Agreement
Boca Raton, FL / Mumbai, India (April, 1 2020) – Florida Pharmaceutical Products, LLC. (FPP) a pharmaceutical company involved in the Development, Sales, Marketing and Distribution of Generic Pharmaceuticals and Inventia Healthcare Limited (Inventia) a company involved in the Development Manufacturing and Licensing of pharmaceuticals are pleased to announce the signing of an agreement for the Licensing, Supply and Distribution of an ANDA developed by Inventia recently approved by the FDA and scheduled to launch this Summer.
The product has sales of approximately $125 million according to IQVIA™. The ANDA product will be sold and Distributed by FPP in the FPP Label with in the US. “We are excited to work with Inventia on this opportunity and look forward to launching the product “, said Larry J. Lapila, President of FPP. The ANDA will be manufactured by Inventia. ” Inventia is excited to add a new partner to the current portfolio of ANDAs and we are working together with FPP towards a successful launch of the product”, said Ankur J. Shah, Whole-time Director of Inventia.
About Florida Pharmaceutical:
Florida Pharmaceutical Products, LLC. (FPP) is a Boca Raton based pharmaceutical company involved in the development of Generic Pharmaceuticals seeking to gain approval and/or license of niche generic products in a broad range of therapeutic areas for marketing and distribution in the US.
Inventia Healthcare Limited is a company headquartered in Mumbai, India; with marketing partners across 28 countries for niche generic oral solid products.
Inventia Healthcare Limited